Hep Par 1 in gastric and bowel carcinomas: an immunohistochemical study

Author： Villari D.   Caruso R.   Grosso M.   Vitarelli E.   Righi M.   Barresi G.  

Publisher： Ashgate Publishing Ltd

ISSN： 0031-3025

Source： Pathology, Vol.34, Iss.5, 2002-10, pp. : 423-426

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An immunohistochemical study of p53 protein in the different histological subtypes of gastric carcinoma

By Teh Ming   Lee Yoke  

Pathology, Vol. 26, Iss. 4, 1994-10 ,pp. : 432-434

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Does HepPar-1 immunoexpression have a role in differential diagnosis of periampullary cancer?

By Gulluoglu Mine   Karayıgıt Ebru   Ozden Ilgin   Kapran Yersu   Dızdaroglu Ferhunde  

Pathology, Vol. 40, Iss. 1, 2008-01 ,pp. : 35-41

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Decreased expression of tumour suppressor Bax‐interacting factor‐1 (Bif‐1), a Bax activator, in gastric carcinomas

By Lee Jong Woo   Jeong Eun Goo   Soung Young Hwa   Nam Suk Woo   Lee Jung Young   Yoo Nam Jin   Lee Sug Hyung  

Pathology, Vol. 38, Iss. 4, 2006-08 ,pp. : 312-315

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Frameshift mutations of ATBF1, WNT9A, CYLD and PARK2 in gastric and colorectal carcinomas with high microsatellite instability

By An Chang Hyeok   Kim Sung Soo   Kang Mi Ran   Kim Yoo Ri   Kim Ho Shik   Yoo Nam Jin   Lee Sug Hyung  

Pathology, Vol. 42, Iss. 6, 2010-10 ,pp. : 583-585

Ashgate Publishing Ltd

Access to resources Recommend Favorite

SMAC/DIABLO mutation is uncommon in gastric and colorectal carcinomas

By Soung Young Hwa   Park Won Sang   Nam Suk Woo   Lee Jung Young   Yoo Nam Jin   Lee Sug Hyung  

Pathology, Vol. 38, Iss. 1, 2006-02 ,pp. : 85-87

Ashgate Publishing Ltd

Access to resources Recommend Favorite